Results 351 to 360 of about 8,631,498 (387)

Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.

Therapeutic Drug Monitoring, 2020
Linezolid is an antibiotic used to treat infections caused by drug-resistant gram-positive organisms, including vancomycin-resistant Enterococcus faecium, multi-drug resistant Streptococcus pneumoniae, and methicillin-resistant Staphylococcus aureus. The
G. Rao, Robyn Konicki, D. Cattaneo, J. Alffenaar, D. Marriott, M. Neely   +5 more
semanticscholar   +1 more source

Cancer Chemotherapy: The Case for Therapeutic Drug Monitoring.

Therapeutic Drug Monitoring, 2020
The selection of an appropriate therapy and dosing regimen is a significant challenge in the treatment of cancer. Although there are recommended standardized chemotherapy protocols for some types of cancer, protocol changes usually only occur after large
Claire E. Knezevic, W. Clarke
semanticscholar   +1 more source

Free Drug Monitoring

Clinics in Laboratory Medicine, 1987
The principles, technique of measurement, and clinical significance of free drugs are reviewed. Albumin, alpha-1-acid glycoprotein, and lipoprotein are the main drug-binding proteins in blood. Variations of the concentrations of these proteins owing to disease would result in changes in the free drug levels.
Benjamin Gerson, Sum Chan
openaire   +3 more sources

Antiarrhythmic Drug Monitoring

Clinics in Laboratory Medicine, 1981
The classification of antiarrhythmic agents by mechanism of action aids the clinician in selecting appropriate antiarrhythmic drug therapy. The pharmacokinetics, the side effects, and the interpretation of serum levels of quinidine, procainamide, disopyramide, lidocaine, and other agents are discussed.
Joan H. Howanitz, Joan H. Howanitz, Peter J. Howanitz, Peter J. Howanitz   +3 more
openaire   +3 more sources

16 Therapeutisches Drug Monitoring Drug Monitoring

2021
Jan Dreher, Verena Lucas
openaire   +2 more sources

Antineoplastic Drug Monitoring

Clinics in Laboratory Medicine, 1987
The ability to monitor biologically significant levels of antineoplastic drugs in patients' plasma is rapidly expanding. The expanded application of therapeutic drug monitoring to the clinical practice of oncology will require a better understanding of the relationship between drug levels, toxicity, and therapeutic benefit in particular patient ...
openaire   +3 more sources

Drug level monitoring: cardiovascular drugs

Journal of Chromatography B: Biomedical Sciences and Applications, 1985
Methods for the determination of cardiovascular drugs in blood and plasma are critically reviewed with emphasis on gas and liquid chromatographic techniques. The importance of the various procedures is discussed, in particular sample work-up where the conditions for isolation and derivatization of the compounds are decisive for the accuracy and ...
Per-Olof Lagerström, Bengt-Arne Persson, Magnar Ervik, Jörgen Vessman, Martin Ahnoff   +4 more
openaire   +3 more sources

Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases

Expert Review of Clinical Immunology, 2019
Introduction: Biologic therapy has revolutionized the treatment of immune mediated inflammatory diseases (IMID), such as inflammatory bowel disease (IBD), rheumatoid and psoriatic arthritis, ankylosing spondylitis and psoriasis.
K. Papamichael, E. Vogelzang, J. Lambert, G. Wolbink, A. Cheifetz   +4 more
semanticscholar   +1 more source

Drug level monitoring of antiasthmatic drugs

Journal of Chromatography B: Biomedical Sciences and Applications, 1985
In general assays pertaining to drug level monitoring (DLM) of antiasthmatic agents (except theophylline), published during the period 1978-1983, used mostly high-performance liquid chromatographic (HPLC) methodology (approximately 45%) with mass spectrometric (MS) based assays in second place (approximately 30%) followed by immunochemical techniques ...
Florence H. Segelman, Norbert Kucharczyk
openaire   +3 more sources

Therapeutic Drug Monitoring of Antiarrhythmic Drugs

Clinical Pharmacokinetics, 2003
Most antiarrhythmic drugs fulfil the formal requirements for rational use of therapeutic drug monitoring, as they show highly variable plasma concentration profiles at a given dose and a direct concentration-effect relationship. Therapeutic ranges for antiarrhythmic drugs are, however, often very poorly defined.
Jens Peter Kampmann, Gesche Jürgens, Niels Graudal   +2 more
openaire   +3 more sources